8.93 USD
-0.13
1.43%
At close Updated Jun 1, 10:16 AM EDT
1 day
-1.43%
5 days
-4.7%
1 month
-4.8%
3 months
-17.85%
6 months
-8.88%
Year to date
-10.7%
1 year
-21.74%
5 years
19.07%
10 years
19.07%
 

About: Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Employees: 24,524

0
Funds holding %
of 8,061 funds
Analysts bullish %
0
Positive news %
Price charts implemented using Lightweight Charts™